https://ojs.bdtopten.com/mchandaids/index.php/IJMA/issue/feed
International Journal of Maternal and Child Health and AIDS (IJMA)
2022-07-06T18:48:17+06:00
Romuladus E. Azuine, DrPH, MPH, RN
submissions@mchandaids.org
Open Journal Systems
<p>The <strong>I</strong>nternational <strong>J</strong>ournal of Maternal and Child Health (<strong>M</strong>CH) and <strong>A</strong>IDS (IJMA) is a multidisciplinary, peer-reviewed, global health, open access journal that publishes original research articles, review articles, methodology articles, field studies or field reports, policy papers, and commentaries in all areas of maternal and child health <strong>(MCH)</strong> and human immunodeficiency virus <strong>(HIV)</strong> and acquired immunodeficiency syndrome <strong>(AIDS)</strong>.</p> <p>IJMA is the only open-access journal that focuses on the social determinants of health and disease and disparities in communicable, non-communicable diseases burden affecting the MCH and HIV/AIDS populations including infants, children, women, men/fathers, and families across the life span.</p> <p>IJMA provides a global forum for the rapid review and publication of papers that advance the science, policy and practice of MCH, pediatrics, child health, women's health, and further interdisciplinary knowledge of prevention, management and care of HIV/AIDS in different populations. The journal provides a forum for the dissemination of work on those at risk of, infected and affected by HIV/AIDS including infants, children, adolescents, women, fathers, families, and communities. <br><br>Diseases or health care issues impacting populations in the developing world are currently under-documented and underreported in existing western-based, peer-reviewed journals. In addition to the above-stated goals, IJMA will address this gap by helping the documentation and dissemination of MCH and HIV/AIDS research, policy and practice from low and middle-income countries. </p> <p><strong>Scope and Areas of Coverage</strong></p> <p>IJMA's scope includes, but is not limited to, the following global MCH and HIV/AIDS issues:</p> <div class="scope-area"> <ul class="scope-area-list"> <li class="show">Maternal (women/mothers) and child (infants, adolescents, youths) health (MCH) epidemiology, care, and practice,</li> <li class="show">HIV/AIDS epidemiology, research, care and practice,</li> <li class="show">Clinical trials and protocols in MCH and HIV/AIDS,</li> <li class="show">Health care and services for MCH and HIV/AIDS populations,</li> <li class="show">Life expectancy, cause-specific mortality, and human development,</li> <li class="show">Maternal, infant, neonatal, child, adolescent, and youth morbidity and mortality,</li> <li class="show">Childhood and adolescent obesity and sedentary behaviors,</li> <li class="show">Smoking, alcohol, substance-use, violence and injury prevention,</li> <li class="show">Mental health in MCH and HIV/AIDS populations,</li> <li class="show">Social, behavioral, and biological determinants of MCH and HIV/AIDS,</li> </ul> <ul class="scope-area-list"> <li class="show">Health and well-being based on gender, race, ethnicity, immigrant status, social class, education, income, disability status, etc.,</li> <li class="show">Region and/or country specific studies using different methodologies,</li> <li class="show">Family health and wellness along the lifespan,</li> <li class="show">Human sexuality and human development,</li> <li class="show">Neglected tropical diseases (NTDs),</li> <li class="show">Technological innovations in MCH and HIV/AIDS,</li> <li class="show">Cross-national research on MCH and HIV/AIDS,</li> <li class="show">Resilience among MCH populations and those impacted by HIV/AIDS,</li> <li class="show">Linkages between research results and national public policy,</li> <li class="show">Applications of surveillance, trend, and multilevel methods, and use of novel approaches in both quantitative and qualitative research studies.</li> </ul> </div>
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/537
Associations of Sociodemographic and Clinical Factors with Late Presentation for Early Infant HIV Diagnosis (EID) Services in Kenya
2021-09-20T19:34:41+06:00
Agnes Langat
vpl4@cdc.gov
Tegan Callahan
uvu1@cdc.gov
Isabella Yonga
iyonga@usaid.gov
Boniface Ochanda
ivq2@cdc.gov
Anthony Waruru
ivq3@cdc.gov
Lucy Ng'anga
hon5@cdc.gov
Abraham Katana
wfo4@cdc.gov
Brian Onyango
bonyango@usaid.gov
Benson Singa
singabi2008A@gmail.com
Stephen Oyule
stephen.oyule@usamru-k.org
George Githuka
ggithuka@nascop.or.ke
Lennah Omoto
ivq2@cdc.gov
Jane Muli
jane.muli@usamru-k.org
Thorkild Tylleskar
Thorkild.Tylleskar@uib.no
Surbhi Modi
bkt1@cdc.gov
<p><strong>Background:</strong> Understanding the missed opportunities in early infant HIV testing within the PMTCT program is essential to address any gaps. The study set out to describe the clinical and sociodemographic characteristics of the infants presenting late for early infant diagnosis in Kenya.</p> <p><strong>Methods:</strong> We abstracted routinely collected clinical and sociodemographic characteristics, in a cross-sectional study, on all HIV-infected infants with a positive polymerase chain reaction (PCR) test from 1,346 President’s Emergency Plan for AIDS Relief (PEPFAR) supported health facilities for the period October 2016 to September 2018. We used multivariate logistic regression to examine the association of sociodemographic and clinical characteristics with late (>2 months after birth) presentation for infant HIV testing.</p> <p><strong>Results:</strong> Of the 4,011 HIV-infected infants identified, the median infant age at HIV diagnosis was 3 months [interquartile range (IQR), 1-16 months], and two-thirds [2,669 (66.5%)] presented late for infant HIV testing. Factors that were associated with late presentation for infant testing were: maternal ANC non-attendance, adjusted odds ratio (aOR) 1.41 (95% confidence interval (CI) 1.18 -1.69); new maternal HIV diagnosis, aOR 1.45, (95%CI 1.24 -1.7); and lack of maternal antiretroviral therapy(ART), aOR 1.94, (95% CI 1.64 - 2.30). There was a high likelihood of identifying HIV-infected infants among infants who presented for medical services in the outpatient setting (aOR 18.9; 95% CI 10.2 - 34.9) and inpatient setting (aOR 12.2; 95% CI 6.23-23.9) compared to the infants who presented late in maternity.</p> <p><strong>Conclusion and Global Health Implications:</strong> Gaps in early infant HIV testing suggest the need to increase maternal pre-pregnancy HIV diagnosis, timely antenatal care, early infant diagnosis services, early identification of mothers who seroconvert during pregnancy or breastfeeding and improved HIV screening in outpatient and inpatient settings. Early referral from the community and access to health facilities should be strengthened by the implementation of national PMTCT guidelines.</p> <p> </p> <p><em>Copyright © 2021 Langat et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-12-13T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/540
Fourth Annual Summer Research Summit on Health Equity Organized by the Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine, Houston, Texas 77030, USA on May 20, 2021
2021-10-12T08:39:41+06:00
Aanand Naik
author@mchandaids.org
Abbhirami Rajagopal
author@mchandaids.org
Adam Floyd
author@mchandaids.org
Adriana Gil
author@mchandaids.org
Aisha Tepede
author@mchandaids.org
Aisha Koroma
author@mchandaids.org
Aisha Deslandes
author@mchandaids.org
Akua Graf
author@mchandaids.org
Alejandra Ruiz-Velasco
author@mchandaids.org
Alexa Reyna-Carrillo
author@mchandaids.org
Alexandra Alvarenga
author@mchandaids.org
Alexia Awoseyi
author@mchandaids.org
Alexis Hernandez
author@mchandaids.org
Alexis Lawrence
author@mchandaids.org
Alexis Hernandez
author@mchandaids.org
Ali Asghar-Ali
author@mchandaids.org
Ali Asghar-Ali
author@mchandaids.org
Allyssa Abacan
author@mchandaids.org
Alyce Adams
author@mchandaids.org
Alyna Khan
author@mchandaids.org
Alyson McGregor
author@mchandaids.org
Alyssa Hansen
author@mchandaids.org
Amari Johnson
author@mchandaids.org
Andrea Coj
author@mchandaids.org
Andrea Vick
author@mchandaids.org
Andria Tatem
author@mchandaids.org
Anjali Aggarwal
author@mchandaids.org
Anjali Deendyal
author@mchandaids.org
Ann Blake
author@mchandaids.org
Annabella Awazi
author@mchandaids.org
Anne VanHorn
author@mchandaids.org
Anuj Marathe
author@mchandaids.org
Anusha Jayaram
author@mchandaids.org
April Adams
author@mchandaids.org
Arabella Hall
author@mchandaids.org
Ariana Heredia
author@mchandaids.org
Ariana Chavarria
author@mchandaids.org
Asha Morrow
author@mchandaids.org
Ashley Butler
author@mchandaids.org
Asia Hodges
author@mchandaids.org
Aura Mejia
author@mchandaids.org
Avani Patel
author@mchandaids.org
Ayleen Hernandez
author@mchandaids.org
Benjamin Akande
author@mchandaids.org
Blessing Felix-Okoroji
author@mchandaids.org
Brisa Garcia
author@mchandaids.org
Buckleitner Jenna
author@mchandaids.org
Callie Fischer
author@mchandaids.org
Camden Hallmark
author@mchandaids.org
Cara Coren
author@mchandaids.org
Carlos Ramos
author@mchandaids.org
Cecilia Gambala
author@mchandaids.org
Charleta Guillory
author@mchandaids.org
Chelsea Livingston
author@mchandaids.org
Chioma Onyejiaka
author@mchandaids.org
Chishinga Callender
author@mchandaids.org
Christina Aldrich
author@mchandaids.org
Christopher Largaespada
author@mchandaids.org
Claire Bocchini
author@mchandaids.org
Craig Cochran
author@mchandaids.org
Danielle Sherman
author@mchandaids.org
Danielle Gonzales
author@mchandaids.org
David Venzon
author@mchandaids.org
David Wittkower
author@mchandaids.org
Debbe Thompson
author@mchandaids.org
Deborah Thompson
author@mchandaids.org
Debra Eseonu
author@mchandaids.org
Deepa Dongarwar
author@mchandaids.org
Delia Rospigliosi
author@mchandaids.org
Denise Smart
author@mchandaids.org
Denisse Velazquez
author@mchandaids.org
Derek Lockett
author@mchandaids.org
Eberechi Nwogu-Onyemkpa
author@mchandaids.org
Elizabeth Byrne
author@mchandaids.org
Elyse Lopez
author@mchandaids.org
Eric Dybbro
author@mchandaids.org
Eric Storch
author@mchandaids.org
Erica Onwuegbuchu
author@mchandaids.org
Erica Valdes
author@mchandaids.org
Erin Donovan
author@mchandaids.org
Eunique Williams
author@mchandaids.org
Evan Keil
author@mchandaids.org
Faith Ihekweazu
author@mchandaids.org
Felicia Rosiji
author@mchandaids.org
Gabriela Espinoza-Candelaria
author@mchandaids.org
Gabriella Chmaitelli
author@mchandaids.org
Gabriella Tavera
author@mchandaids.org
Gail Oneal
author@mchandaids.org
Gal Barbut
author@mchandaids.org
Gauvain Tonpouwo
author@mchandaids.org
George Carrum
author@mchandaids.org
Gina DeFelice
author@mchandaids.org
Hamisu Salihu
author@mchandaids.org
Heather Haq
author@mchandaids.org
Helen Heslop
author@mchandaids.org
Houston Lester
author@mchandaids.org
Ifeoma Ezenwabachili
author@mchandaids.org
Ila Gautham
author@mchandaids.org
Jacquelin Powell
author@mchandaids.org
Jaime Alleyn
author@mchandaids.org
Jasmine King
author@mchandaids.org
Jaydira Rivero
author@mchandaids.org
Jayer Chung
author@mchandaids.org
Jayna Dave
author@mchandaids.org
Jean Raphael
author@mchandaids.org
Jen Bryan
author@mchandaids.org
Jendi Haug
author@mchandaids.org
Jennifer Bryan
author@mchandaids.org
Jenny Blau
author@mchandaids.org
Jerry Bellamy
author@mchandaids.org
Jessica Medrano
author@mchandaids.org
Jessica Ramirez
author@mchandaids.org
Jocelyn Greely
author@mchandaids.org
Jonnae Atkinson
author@mchandaids.org
Jorge Miranda
author@mchandaids.org
Jose Dominguez
author@mchandaids.org
Jose Roca
author@mchandaids.org
Joseph Mills
author@mchandaids.org
Joshua Hamer
author@mchandaids.org
Joshua Muñiz
author@mchandaids.org
Julliet Ogu
author@mchandaids.org
Karen Gibbs
author@mchandaids.org
Karen Johnson
author@mchandaids.org
Karen Riggins
author@mchandaids.org
Karla Fredricks
author@mchandaids.org
Keila Lopez
author@mchandaids.org
Kellie Williams
author@mchandaids.org
Keyishi Peters
author@mchandaids.org
Kil Hyein
author@mchandaids.org
LaQuisa Hill
author@mchandaids.org
Lee Weinstein
author@mchandaids.org
Lena Shay
author@mchandaids.org
Lentz Lefevre
author@mchandaids.org
Lindy Ross
author@mchandaids.org
Lisa Noll
author@mchandaids.org
Lois Akpati
author@mchandaids.org
Lorin Crear
author@mchandaids.org
Lucy Puryear
author@mchandaids.org
Maame Coleman
author@mchandaids.org
Madhuri Vasudevan
author@mchandaids.org
Malachi Miller
author@mchandaids.org
Maria Vigil-Mallette
author@mchandaids.org
Maria Jaramillo
author@mchandaids.org
Maria Vigil-Mallette
author@mchandaids.org
Mariam Chacko
author@mchandaids.org
Mariana Baroni
author@mchandaids.org
Mariana Murillo
author@mchandaids.org
Maricarmen Marroquin
author@mchandaids.org
Marina Masciale
author@mchandaids.org
Marlene McNeese
author@mchandaids.org
Martinez Austin
author@mchandaids.org
Matthew Koller
author@mchandaids.org
Maya Lee
author@mchandaids.org
Maziar Nourian
author@mchandaids.org
Megan Abadom
author@mchandaids.org
Meghna Sebastian
author@mchandaids.org
Meheret Adera
author@mchandaids.org
Mei-Lei Laracuente
author@mchandaids.org
Michelle Lopez
author@mchandaids.org
Michelle Wright
author@mchandaids.org
Miguel Montero-Baker
author@mchandaids.org
Monica Gonzalez
author@mchandaids.org
Morrow Adelene
author@mchandaids.org
Mosope Adeyeye
author@mchandaids.org
Muzaffar Qazilbash
author@mchandaids.org
Namrata Walia
author@mchandaids.org
Nancy Shenoi
author@mchandaids.org
Natalia Rodriguez
author@mchandaids.org
Naya Mukdadi
author@mchandaids.org
Neeraj Saini
author@mchandaids.org
Norma Olvera
author@mchandaids.org
Ololade Chris-Rotimi
author@mchandaids.org
Paige Hoyer
author@mchandaids.org
Parisa Fallah
author@mchandaids.org
Peggy Smith
author@mchandaids.org
Premal Lulla
author@mchandaids.org
Priscilla Ehieze
author@mchandaids.org
Priyanka Murali
author@mchandaids.org
Rachel Head
author@mchandaids.org
Rachel Nwaneri
author@mchandaids.org
Rachelle Wanser
author@mchandaids.org
Racquel Lyn
author@mchandaids.org
Rammurti Kamble
author@mchandaids.org
Ramyar Gilani
author@mchandaids.org
Raquel Martinez
author@mchandaids.org
Rathi Asaithambi
author@mchandaids.org
Reginald Hatter
author@mchandaids.org
Rhanna Wilson
author@mchandaids.org
Ria Brown
author@mchandaids.org
Robert Shulman
author@mchandaids.org
Robert Mbilinyi
author@mchandaids.org
Robert Levine
author@mchandaids.org
Roe Avery
author@mchandaids.org
Romil Patel
author@mchandaids.org
Roslyn Aduhene-Opoku
author@mchandaids.org
Ruth Mizu
author@mchandaids.org
Saad Usmani
author@mchandaids.org
Sadia Usmani
author@mchandaids.org
Saeed Ahmed
author@mchandaids.org
Samantha Moore
author@mchandaids.org
Samer Hadidi
author@mchandaids.org
Sana Erabti
author@mchandaids.org
Sana Javed
author@mchandaids.org
Sana Younus
author@mchandaids.org
Sanders Mar’Quenda
author@mchandaids.org
Sandy Samaan
author@mchandaids.org
Sara Alam
author@mchandaids.org
Sara Welty
author@mchandaids.org
Sergio Navarro
author@mchandaids.org
Shad Deering
author@mchandaids.org
Shaine Morris
author@mchandaids.org
Shana Alford
author@mchandaids.org
Shangir Siddique
author@mchandaids.org
Shantyka Walton
author@mchandaids.org
Shayan Bhathena
author@mchandaids.org
Shelease O’Bryant
author@mchandaids.org
Shital Patel
author@mchandaids.org
Sindhu Idicula
author@mchandaids.org
Sophia Banu
author@mchandaids.org
Sophie Albert
author@mchandaids.org
Sophie McCullum
author@mchandaids.org
Sophie Lin
author@mchandaids.org
Star Okolie
author@mchandaids.org
Sunita Agarwal
author@mchandaids.org
Susan Gillespie
author@mchandaids.org
Syed Hussaini
author@mchandaids.org
Sylvia Hysong
author@mchandaids.org
Tammy Kang
author@mchandaids.org
Tara Everett
author@mchandaids.org
Tara Everett
author@mchandaids.org
Taylor Ottesen
author@mchandaids.org
Tiana DiMasi
author@mchandaids.org
Tien Nguyen
author@mchandaids.org
Toi Harris
author@mchandaids.org
Tzu-An Chen
author@mchandaids.org
Vicki Mercado
author@mchandaids.org
Victoria Michael
author@mchandaids.org
Victoria Xie
author@mchandaids.org
William Simonds
author@mchandaids.org
Yesenya Gonzalez
author@mchandaids.org
Yicenia Aviles
author@mchandaids.org
Ynhi Thomas
author@mchandaids.org
Zachary Pallister
author@mchandaids.org
<p>The fourth annual summer research summit organized by the Center of Excellence (COE) in Health Equity, Training and Research, Baylor College of Medicine (BCM) was held on May 20, 2021. The theme of this year’s summit was ‘Strengthening Our Commitment to Racial and Social Justice to Improve Public Health.’ Given the ongoing pandemic, the summit was conducted virtually through digital platforms. This program was intended for both BCM and external audiences interested in advancing health equity, diversity and inclusion in healthcare among healthcare providers and trainees, biomedical scientists, social workers, nurses, individuals involved in talent acquisition and development such as hiring managers (HR professionals), supervisors, college and hospital affiliate leadership and administrators, as well as diversity and inclusion excellence practitioners. We had attendees from all regions of the United States, India, Pakistan and the Demographic Republic of the Congo. The content in this Book of Abstracts encapsulates a summary of the research efforts by the BCM COE scholars (which includes post-baccalaureate students, medical students, clinical fellows and junior faculty from BCM) as well as the external summit participants. The range of topics in this year’s summit was quite diverse encompassing disparities in relation to maternal and child health (MCH), immigrant heath, cancers, vaccination uptakes and COVID-19 infections. Various solutions were ardently presented to address these disparities including community engagement and partnerships, improvement in health literacy and development of novel technologies and therapeutics. With this summit, BCM continues to build on its long history of educational outreach initiatives to promote diversity in medicine by focusing on programs aimed at increasing the number of diverse and highly qualified medical professionals ready to introduce effective and innovative approaches to reduce or eliminate health disparities. These programs will improve information resources, clinical education, curricula, research and cultural competence as they relate to minority health issues and social determinants of health. The summit received very positive response in terms of zealous participation and outstanding evaluations; and overall, it was a great success.</p> <p> </p> <p><em>Copyright © 2021 Dongarwar et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-10-20T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/525
Determinants of HIV Testing Uptake among Women (aged 15-49 years) in the Philippines, Myanmar, and Cambodia
2021-09-13T21:15:14+06:00
Wah Myint
wah@tamu.edu
David Washburn
dwashburn@tamu.edu
Brian Colwell
b-colwell@tamu.edu
Jay Maddock
maddock@tamu.edu
<p><strong>Background:</strong> Many countries have been trying to eliminate Mother-to-Child transmission of the Human Immunodeficiency Virus (HIV) and achieve the 90-90-90 target goals. The targets mean that 90% of People Living with HIV (PLWHIV) know their HIV status, 90% of those who are infected receive Antiretroviral treatment (ART), and 90% of those achieve viral suppression. Despite some progress, the goals have not been met in the Philippines, Myanmar, and Cambodia, countries with relatively high or growing HIV prevalence. This study identifies the sociodemographic determinants of testing among women in these countries so that better health education and stigma reduction strategies can be developed.</p> <p><strong>Methods:</strong> Descriptive and multivariable analyses were conducted using Demographic and Health Survey data conducted in the Philippines (2017), Myanmar (2015/2016), and Cambodia (2014). The outcome variable was having ever been tested for HIV. Independent variables included knowledge and attitudes about HIV and social determinants of health.</p> <p><strong>Results:</strong> A significant difference in testing rates among women was observed (the Philippines: 5%, Myanmar: 19%, Cambodia: 42%). In Myanmar and Cambodia, women who had more HIV knowledge and less stigma towards PLWHIV were more likely to get tested for HIV than those who did not. Marital status, education, wealth were strong predictors for HIV testing among women. Younger women aged 15-19 and those who live in the rural areas were less likely to get HIV tested than older and those living in urban areas. Employed women were less likely to seek an HIV test than the unemployed in Myanmar and Cambodia, whereas, in the Philippines, the opposite relationship was found.</p> <p><strong>Conclusion and Global Health Implications:</strong> Women with less education and those less familiar with HIV should be targeted for HIV testing interventions. Stigma reduction and different testing strategies could facilitate early screening leading to improved HIV testing among women.</p> <p> </p> <p><em>Copyright © 2021 Myint et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-12-02T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/524
Geographic, Health Care Access, Racial Discrimination, and Socioeconomic Determinants of Maternal Mortality in Georgia, United States
2021-09-20T20:04:57+06:00
Elizabeth Afibah Armstrong-Mensah
earmstrongmensah@gsu.edu
Damilola Dada
ddada1@student.gsu.edu
Amber Bowers
abowers6@student.gsu.edu
Aruba Muhammad
amuhammad30@student.gsu.edu
Chisom Nnoli
cnnoli1@student.gsu.edu
<p>Over the past decade, the United States has been taking steps to reduce its rising maternal mortality rate. However, these steps have yet to produce positive results in the state of Georgia, which tops the list of all 50 states with the highest maternal mortality rate of 46.2 maternal deaths per 100,000 live births for all women, and a maternal mortality rate of 66.6 deaths per 100,000 live births for African American women. In Georgia, several social determinants of health such as the physical environment, economic stability, health care access, and the quality of maternal care contribute to the high maternal mortality rate. Addressing these determinants will help to reduce the state’s maternal mortality rate. This commentary discusses the relationship between social determinants of health and maternal mortality rates in Georgia. It also proposes strategies for reversing the trend.We conducted an ecological study of the relationship between social determinants of health and maternal mortality in Georgia. We searched PubMed and Google Scholar and reviewed 80 English articles published between 2005 and 2021. We identified five key social determinants associated with high maternal mortality rates in Georgia - geographic location of obstetric services, access to health care providers, socioeconomic status, racism, and discrimination. We found that expanding Medicaid coverage, reducing maternal health care disparities among the races, providing access to maternal care for women in rural areas, and training a culturally competent health workforce, will help to reduce Georgia’s high maternal mortality rate.</p> <p> </p> <p><em>Copyright © 2021 Armstrong-Mensah et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-12-13T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/523
Genital Chlamydia Trachomatis Infection: Prevalence, Risk Factors and Adverse Pregnancy and Birth Outcomes in Children and Women in sub-Saharan Africa
2021-09-06T04:24:39+06:00
Elizabeth Afibah Armstrong-Mensah
earmstrongmensah@gsu.edu
David-Praise Ebiringa
david-praise.ebiringa@emory.edu
Kaleb Whitfield
kwhitfield@msm.edu
Jake Coldiron
jcoldiron1@student.gsu.edu
<p>Genital Chlamydia trachomatis (CT) has adverse health outcomes for women and children. In pregnant women, the infection causes adverse obstetric outcomes including pelvic inflammation, ectopic pregnancy, and miscarriage. In children, it causes adverse birth outcomes such as skin rash, lesions, limb abnormalities, conjunctivitis, neurological damage, and even death. This article discusses genital CT prevalence, risk factors, and adverse pregnancy and birth outcomes among women and children in sub-Saharan Africa as well as challenges associated with the mitigation of the disease. A comprehensive search of databases including PubMed, ResearchGate, and Google Scholar was conducted using keywords such as genital chlamydia trachomatis, adverse pregnancy outcomes, adverse birth outcomes, and sub-Saharan African. We found that genital CT prevalence rates in some sub-Saharan Africa countries were higher than others and that risk factors such as the lack of condom use, having multiple sexual partners, and low educational levels contribute to the transmission of the infection. We also found that negative cultural practices, illiteracy among women, and the lack of access to screening services during pregnancy are some of the challenges associated with CT mitigation in sub-Saharan Africa. To reduce genital CT transmission in sub-Saharan Africa, efforts must be made by country governments to eliminate negative cultural practices, promote female literacy, and provide access to screening services for pregnant women.</p> <p> </p> <p><em>Copyright © 2021 Armstrong-Mensah et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-12-02T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/520
An Analysis of Levels and Trends in HIV Prevalence Among Pregnant Women Attending Antenatal Clinics in Karnataka, South India, 2003-2019
2021-07-29T09:22:43+06:00
Arumugam Elangovan
elangovan@nie.gov.in
Joseph K David
drjosephkdavid@gmail.com
Santhakumar Aridoss
santhakumar.aridoss@gmail.com
Nagaraj Jaganathasamy
nagarajicmr@gmail.com
Malathi Mathiyazhakan
mithmals@gmail.com
Balasubramanian Ganesh
niedrbganesh@gmail.com
Manikandan Natesan
maninatesan87@gmail.com
Padmapriya VM
padmanie2019@gmail.com
Kirubakaran BK
bkkirubakaran@hotmail.com
Sanjay Patil
ddmandeksaps@gmail.com
Pradeep Kumar
posurveillance.naco@gmail.com
Shobini Rajan
shobini.simu.naco@gmail.com
<p><strong>Background and Objective:</strong> Periodic tracking of the trends and the levels of HIV prevalence at regional and district levels helps to strengthen a state’s HIV/AIDS response. HIV prevalence among pregnant women is crucial for the HIV prevalence estimation of the general population. Karnataka is one of the high HIV prevalence states in India. Probing regional and district levels and trends of HIV prevalence provides critical insights into district-level epidemic patterns. This paper analyzes the region- and district-wise levels and trends of HIV prevalence among pregnant women attending the antenatal clinics (ANC) from 2003 to 2019 in Karnataka, South India.</p> <p><strong>Methods:</strong> HIV prevalence data collected from pregnant women in Karnataka during HIV Sentinel Surveillance (HSS) between 2003 and 2019 was used for trend analysis. The consistent sites were grouped into four zones (Bangalore, Belgaum, Gulbarga and Mysore regions), totaling 60 sites, including 30 urban and 30 rural sites. Regional and district-level HIV prevalence was calculated; trend analysis using Chi-square trend test and spatial analysis using QGIS software was done. For the last three HSS rounds, HIV prevalence based on sociodemographic variables was calculated to understand the factors contributing to HIV positivity in each region.</p> <p><strong>Results:</strong> In total, 254,563 pregnant women were recruited. HIV prevalence in Karnataka was 0.22 (OR: 0.15 95% CI: 0.16 - 0.28) in 2019. The prevalence was 0.24, 0.32, 0.17 and 0.14 in Bangalore, Belgaum, Gulbarga, and Mysore regions, respectively. HIV prevalence had significantly (P< 0.05) declined in 26 districts.</p> <p><strong>Conclusion and Global Health Implications:</strong> HIV prevalence among pregnant women was comparatively higher in Bangalore and Belgaum regions. Analysis of contextual factors associated with the transmission risk and evidence-based targeted interventions will strengthen HIV management in Karnataka. Regionalized, disaggregated, sub-national analyses will help identify emerging pockets of infections, concentrated epidemic zones and contextual factors driving the disease transmission.</p> <p> </p> <p><em>Copyright © 2021. Arumugam et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-11-01T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/517
Strengthening Maternal Death Surveillance Systems for Evidence-Based Decision Making in Sub-Saharan Africa: The Case of the Center Region in Cameroon
2021-09-27T20:43:43+06:00
Anastasia Bongajum Yenban
anasta_siauk@yahoo.com
Pascal Foumane
author@mchandaids.org
Charlotte Moussi
author@mchandaids.org
Noel Vogue
author@mchandaids.org
Hycinth Banseka
author@mchandaids.org
Jujlius Nwobegahay
author@mchandaids.org
Martina Baye
author@mchandaids.org
<p><strong>Background:</strong> The article seeks to document the experience of implementing Maternal Death Surveillance and Response (MDSR) in the Center Region of Cameroon. The paper raises awareness on the need for implementing MDSR, shares progress and lessons learned and reflects on the implications for public health practice.</p> <p><strong>Methods:</strong> A desk research involving the collection and analysis of secondary data using tables with specific themes in excel, following the review of existing resources at the Regional Delegation of Public Health-Center from the year 2016 to 2019.</p> <p><strong>Results:</strong> The findings depict the existence of MDSR policies and sub-regional committees. Although, the number of regional maternal death notifications increased from 19 to 188 deaths between 2016 and 2019, the implementation of death review recommendations was only estimated at 10% in 2019. While 66% of deaths occurred in Yaoundé, 72% of these were deaths reported to have occurred in tertiary institutions out of which 75% were attributed to late referrals. Hemorrhage constituted 70/144 (48.6%) of the known direct causes of death. Maternal death related co-factors such as the use of partograph during labor had a high non-response rate (84%) and represents a weakness in the data set.</p> <p><strong>Conclusion and Global Health Implications:</strong> Across the board, stakeholder engagement towards MDSR was increased through continuous awareness-raising, dissemination of surveillance tools, the institutionalization of the District Health Information Software (DHIS 2) and the “No Name No Blame” policy. However, the reporting and investigation of deaths for informed decisions remain a daunting challenge. For a resource-scarce setting with limited access to blood banks, the application of life-saving cost-effective interventions such as the use of partographs and the institution of a functional referral system among health units is likely to curb the occurrence of deaths from hemorrhage and other underlying causes. The success of these will require a robust strengthening of the health system.</p> <p> </p> <p><em>Copyright © 2021 Bongajum, et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-12-01T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/511
Pregnancy and Birth Outcomes Among Women on Antiretroviral Therapy: A Long-term Retrospective Analysis of Data from a Major Tertiary Hospital in North Central Nigeria
2021-07-25T18:30:33+06:00
Maxwell Dapar
daparm@unijos.edu.ng
Benjamin Joseph
Josephb@unijos.edu.ng
Rotkangmwa Okunola
okunlolar@unijos.edu.ng
Josiah Mutihir
jtmutihir01@yahoo.co.uk
Moses Chingle
chinglem@unijos.edu.ng
Mathilda Banwat
mathildabanwat@yahoo.com
<p><strong>Background and Objective:</strong> Antiretroviral therapy (ART) has transformed human immune deficiency virus (HIV) infection from a death sentence to a chronic syndrome, allowing infected individuals to lead near-normal lives, including achieving pregnancy and bearing children. Notwithstanding, concerns remain about the effects of ART in pregnancy. Previous studies suggested contradictory associations between ART and pregnancy. This study determined birth outcomes in pregnant women who accessed ART between 2004 and 2017 at a major tertiary hospital in North Central Nigeria.</p> <p><strong>Methods:</strong> This was a retrospective study of 5,080 participants. Ethical clearance was obtained from the Institutional Review Board of the Harvard T. H. Chan School of Public Health Boston. A pro forma for data abstraction was designed and used to collect data. Abstracted data were sorted and managed using SPSS® version 22. The Chi-square test was used to calculate the proportions of pregnancy outcomes. One-way analysis of variance was used to test the effect of antiretroviral drug regimens on mean birth weight and gestational age at delivery. All levels of significance were set at p 0.05.</p> <p><strong>Results:</strong> Pregnancy outcomes were recorded as live birth (99.8%), stillbirth (0.2%), preterm delivery (6.6%), and low birth weight (23%). There was a statistically significant association between ART in pregnancy and low birth weight {χ2[(5, n = 3439) = 11.99, p = 0.04]}. The highest mean birth weights were recorded in participants who received drug combinations with protease inhibitors or efavirenz, in contrast to participants who received Nevirapine, stavudine and Emtricitabine/Tenofovirbased regimens. However, there was no significant difference in the gestational age of babies at birth for the six ART regimens in the study.</p> <p><strong>Conclusion and Global Health Implications:</strong> Findings support the benefits of ART in pregnancy, which is in line with the testing and treatment policies of the 90-90-90 targets for ending HIV by the year 2030.</p> <p> </p> <p><em>Copyright © 2021 Dapar et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-10-28T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/510
A Review and Analysis of Outcomes from Prevention of Mother-to- Child Transmission of HIV Infant Follow-up Services at a Pediatric Infectious Diseases Unit of a Major Tertiary Hospital in Nigeria: 2007-2020
2021-07-04T20:03:58+06:00
EBELECHUKU FRANCESCA UGOCHUKWU
ef.ugochukwu@unizik.edu.ng
CHINYERE UKAMAKA ONUBOGU
cu.onubogu@unizik.edu.ng
EMEKA STEPHEN EDOKWE
es.edokwe@unizik.edu.ng
UCHENNA EKWOCHI
uekwochi@yahoo.co.uk
KENNETH NCHEKWUBE OKEKE
kn.okeke@unizik.edu.ng
ESTHER NGOZI UMEADI
en.umeadi@unizik.edu.ng
STANLEY KENECHI ONAH
sk.onah@unizik.edu.ng
<p><strong>Background and Objective:</strong> Above 90% of childhood HIV infections result from mother-to child transmission (MTCT). This study examined the MTCT rates of HIV-exposed infants enrolled in the infant follow-up arm of the prevention of mother-to-child transmission (PMTCT) program in a teaching hospital in Southeast Nigeria.</p> <p><strong>Methods:</strong> This was a 14-year review of outcomes of infants enrolled in the infant follow-up arm of the PMTCT program of Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria. The majority of subjects were enrolled within 72 hours of birth and were followed up until 18 months of age according to the National Guidelines on HIV prevention and treatment. At enrollment, relevant data were collected prospectively, and each scheduled follow-up visit was recorded both electronically and in physical copy in the client’s folders. Data were analyzed using SPSS version 20. The major outcome variable was final MTCT status.</p> <p><strong>Results:</strong> Out of 3,784 mother-infant dyads studied 3,049 (80.6%) received both maternal and infant Antiretroviral (ARV) prophylaxis while 447 (11.8%) received none. The MTCT rates were 1.4%, 9.3%, 24.1%, and 52.1% for both mother and infant, mother only, infant only, and none received ARV prophylaxis respectively. There was no gender-based difference in outcomes. The MTCT rate was significantly higher among mixed-fed infants (p<0.001) and among those who did not receive any form of ARVs (p<0.001). Among dyads who received no ARVs, breastfed infants significantly had a higher MTCT rate compared to never breastfed infants (57.9% vs. 34.8%; p<0.001). The MTCT rate was comparable among breastfed (2.5%) and never-breastfed (2.1%) dyads who had received ARVs. After logistic regression, maternal (p<0.001, OR: 7.00) and infant (p<0.001, OR: 4.00) ARV prophylaxis for PMTCT remained significantly associated with being HIV-negative.</p> <p><strong>Conclusion and Global Health Implications:</strong> Appropriate use of ARVs and avoidance of mixed feeding in the first six months of life are vital to the success of PMTCT programs in developing countries. PMTCT promotes exclusive breastfeeding and reduces the burden of pediatric HIV infection, thereby enhancing child survival.</p> <p> </p> <p><em>Copyright © 2021 Ugochukwu et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-12-15T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)
https://ojs.bdtopten.com/mchandaids/index.php/IJMA/article/view/509
A Comparison of Postoperative Surgical Outcomes among Women Undergoing Obstetric Fistula Repair with and without HIV
2021-08-23T05:24:36+06:00
Prakash Ganesh
pxg161@case.edu
Rachel Mernoff
author@mchandaids.org
Renske Dikkers
author@mchandaids.org
William Nundwe
author@mchandaids.org
Rachel Pope
author@mchandaids.org
<p><strong>Background and Objective:</strong> Obstetric fistula affects approximately 2 million women worldwide, predominantly in places with a high Human Immunodeficiency Virus (HIV) burden. In Malawi, where thousands of women live with fistulas, HIV prevalence is 11-13%. Although repair is usually successful, surgical outcomes among immunocompromised women are poorly understood. Inconsistent guidelines regarding the Cluster of Differentiation 4 (CD4) threshold necessary for repair make it difficult for surgeons to make informed decisions. This study compares the postoperative outcomes of women undergoing obstetric fistula repair with and without HIV, stratified by CD4 count.</p> <p><strong>Methods:</strong> This is a retrospective case-control study using a database of women who underwent vesicovaginal fistula repair at the Fistula Care Center from 2010-2018. HIV-positive participants, stratified by CD4<350 and CD4>350, were matched to HIV-negative controls by age within 5 years and Goh classification. Controls were matched to cases in a 3:1 ratio. Bivariate analysis and logistic regression were conducted on indicators based on HIV status and CD4 count stratification. Outcomes included dye test results, pad weights, and continence status at 2 weeks post-repair.</p> <p><strong>Results:</strong> 54 seropositive women were matched to 135 seronegative women. Of the 54 HIV positive women, 22.2% (n=12) had a CD4 count < 350. We found no statistically significant difference in surgical outcomes between HIV-positive and negative patients. 93.5% of HIV positive and 90% of HIV negative women healed completely. In our sub-analysis of 12 seropositive women with CD4<350, we found a statically significant difference in successful closure, with 25% of women with CD4<350 having a positive dye test indicating incomplete closure, compared to 2.8% of women with CD4>350 (p=0.024).</p> <p><strong>Conclusion and Global Health Implications:</strong> Our analysis confirms previous research indicating that seropositive women with a CD4>350 can safely undergo obstetric fistula repair. Further research is needed to evaluate postoperative outcomes among women with CD4<350.</p> <p> </p> <p><em>Copyright © 2021 Ganesh et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License <strong>CC BY 4.0</strong>.</em></p>
2021-10-30T00:00:00+06:00
Copyright (c) 2021 International Journal of Maternal and Child Health and AIDS (IJMA)